AstraZeneca PLC (BVMF:A1ZN34)

AstraZeneca Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 5, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,553,833	1,256,595	1,015,431	1,107,234	1,014,241	681,653
Market Cap Growth	22.93%	23.75%	-8.29%	9.17%	48.79%	28.30%
Enterprise Value	1,683,630	1,411,241	1,139,326	1,260,280	1,167,385	778,131
Last Close Price	165.04	132.26	104.00	111.93	-	-
PE Ratio	31.02	28.88	35.14	63.70	1625.31	41.07
PS Ratio	5.02	3.76	4.57	4.72	4.87	4.93
PB Ratio	6.34	4.97	5.34	5.65	4.63	8.39
P/FCF Ratio	23.03	20.45	23.29	24.03	37.36	34.20
P/OCF Ratio	19.26	17.13	20.23	21.35	30.53	27.35
EV/Sales Ratio	5.48	4.22	5.13	5.38	5.60	5.63
EV/EBITDA Ratio	15.36	12.99	16.51	17.35	31.27	21.44
EV/EBIT Ratio	20.04	17.65	24.34	27.05	72.32	34.29
EV/FCF Ratio	24.96	22.96	26.14	27.35	43.01	39.04
Debt / Equity Ratio	0.71	0.75	0.76	0.84	0.85	1.45
Debt / EBITDA Ratio	1.57	1.70	2.04	2.23	4.81	3.15
Debt / FCF Ratio	2.58	3.07	3.30	3.57	6.85	5.92
Asset Turnover	0.53	0.53	0.46	0.44	0.44	0.42
Inventory Turnover	1.59	1.80	1.59	1.26	1.85	1.45
Quick Ratio	0.69	0.67	0.58	0.62	0.67	0.67
Current Ratio	0.88	0.93	0.82	0.86	1.16	0.96
Return on Equity (ROE)	21.67%	17.59%	15.64%	8.63%	0.42%	20.80%
Return on Assets (ROA)	9.06%	7.88%	6.10%	5.46%	2.10%	4.26%
Return on Invested Capital (ROIC)	18.54%	16.27%	13.35%	13.75%	6.00%	11.87%
Return on Capital Employed (ROCE)	19.80%	17.00%	13.70%	12.60%	3.50%	9.40%
Earnings Yield	3.22%	3.46%	2.85%	1.57%	0.06%	2.44%
FCF Yield	4.34%	4.89%	4.29%	4.16%	2.68%	2.92%
Dividend Yield	1.68%	14.50%	13.53%	13.70%	-	-
Payout Ratio	52.89%	65.80%	75.25%	132.72%	3442.86%	111.77%
Buyback Yield / Dilution	0.08%	-0.06%	-0.13%	-9.32%	-8.68%	-0.92%
Total Shareholder Return	1.76%	14.43%	13.40%	4.38%	-8.68%	-0.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.